Literature DB >> 25772705

Enhanced ratio of signals enables digital mutation scanning for rare allele detection.

Elena Castellanos-Rizaldos1, Cloud Paweletz2, Chen Song1, Geoffrey R Oxnard3, Harvey Mamon4, Pasi A Jänne5, G Mike Makrigiorgos6.   

Abstract

The use of droplet digital PCR (ddPCR) for low-level DNA mutation detection in cancer, prenatal diagnosis, and infectious diseases is growing rapidly. However, although ddPCR has been implemented successfully for detection of rare mutations at pre-determined positions, no ddPCR adaptation for mutation scanning exists. Yet, frequently, clinically relevant mutations reside on multiple sequence positions in tumor suppressor genes or complex hotspot mutations in oncogenes. Here, we describe a combination of coamplification at lower denaturation temperature PCR (COLD-PCR) with ddPCR that enables digital mutation scanning within approximately 50-bp sections of a target amplicon. Two FAM/HEX-labeled hydrolysis probes matching the wild-type sequence are used during ddPCR. The ratio of FAM/HEX-positive droplets is constant when wild-type amplicons are amplified but deviates when mutations anywhere under the FAM or HEX probes are present. To enhance the change in FAM/HEX ratio, we employed COLD-PCR cycling conditions that enrich mutation-containing amplicons anywhere on the sequence. We validated COLD-ddPCR on multiple mutations in TP53 and in EGFR using serial mutation dilutions and cell-free circulating DNA samples, and demonstrate detection down to approximately 0.2% to 1.2% mutation abundance. COLD-ddPCR enables a simple, rapid, and robust two-fluorophore detection method for the identification of multiple mutations during ddPCR and potentially can identify unknown DNA variants present in the target sequence.
Copyright © 2015 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25772705      PMCID: PMC4411249          DOI: 10.1016/j.jmoldx.2014.12.003

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  37 in total

1.  COLD-PCR enrichment of rare cancer mutations prior to targeted amplicon resequencing.

Authors:  Coren A Milbury; Mick Correll; John Quackenbush; Renee Rubio; G Mike Makrigiorgos
Journal:  Clin Chem       Date:  2011-12-21       Impact factor: 8.327

2.  Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography.

Authors:  D J Marsh; G Theodosopoulos; V Howell; A L Richardson; D E Benn; A L Proos; C Eng; B G Robinson
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

3.  Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.

Authors:  Pietro Carotenuto; Cristin Roma; Salvatore Cozzolino; Francesca Fenizia; Anna Maria Rachiglio; Fabiana Tatangelo; Alessia Iannaccone; Luigi Baron; Gerardo Botti; Nicola Normanno
Journal:  Int J Oncol       Date:  2011-10-04       Impact factor: 5.650

4.  Circulating mutant DNA to assess tumor dynamics.

Authors:  Frank Diehl; Kerstin Schmidt; Michael A Choti; Katharine Romans; Steven Goodman; Meng Li; Katherine Thornton; Nishant Agrawal; Lori Sokoll; Steve A Szabo; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz
Journal:  Nat Med       Date:  2007-07-31       Impact factor: 53.440

5.  GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma.

Authors:  David Delaney; Tim C Diss; Nadege Presneau; Sandra Hing; Fitim Berisha; Bernadine D Idowu; P O'Donnell; John A Skinner; Roberto Tirabosco; Adrienne M Flanagan
Journal:  Mod Pathol       Date:  2009-03-13       Impact factor: 7.842

6.  Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA.

Authors:  Geoffrey R Oxnard; Cloud P Paweletz; Yanan Kuang; Stacy L Mach; Allison O'Connell; Melissa M Messineo; Jason J Luke; Mohit Butaney; Paul Kirschmeier; David M Jackman; Pasi A Jänne
Journal:  Clin Cancer Res       Date:  2014-01-15       Impact factor: 12.531

7.  Antiprimer quenching-based real-time PCR and its application to the analysis of clinical cancer samples.

Authors:  Jin Li; Fengfei Wang; Harvey Mamon; Matthew H Kulke; Lyndsay Harris; Elizabeth Maher; Lilin Wang; G Mike Makrigiorgos
Journal:  Clin Chem       Date:  2006-02-09       Impact factor: 8.327

8.  Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing.

Authors:  Azeet Narayan; Nicholas J Carriero; Scott N Gettinger; Jeannie Kluytenaar; Kevin R Kozak; Torunn I Yock; Nicole E Muscato; Pedro Ugarelli; Roy H Decker; Abhijit A Patel
Journal:  Cancer Res       Date:  2012-05-10       Impact factor: 12.701

9.  Temperature-tolerant COLD-PCR reduces temperature stringency and enables robust mutation enrichment.

Authors:  E Castellanos-Rizaldos; Pingfang Liu; Coren A Milbury; Minakshi Guha; Angela Brisci; Laura Cremonesi; Maurizio Ferrari; Harvey Mamon; G Mike Makrigiorgos
Journal:  Clin Chem       Date:  2012-05-15       Impact factor: 8.327

10.  Differential strand separation at critical temperature: a minimally disruptive enrichment method for low-abundance unknown DNA mutations.

Authors:  Minakshi Guha; Elena Castellanos-Rizaldos; Pingfang Liu; Harvey Mamon; G Mike Makrigiorgos
Journal:  Nucleic Acids Res       Date:  2012-12-20       Impact factor: 16.971

View more
  10 in total

1.  Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR.

Authors:  Jennifer B Jackson; Daniel S Choi; James D Luketich; Arjun Pennathur; Anders Ståhlberg; Tony E Godfrey
Journal:  J Mol Diagn       Date:  2016-01-02       Impact factor: 5.568

2.  DMSO Increases Mutation Scanning Detection Sensitivity of High-Resolution Melting in Clinical Samples.

Authors:  Chen Song; Elena Castellanos-Rizaldos; Rafael Bejar; Benjamin L Ebert; G Mike Makrigiorgos
Journal:  Clin Chem       Date:  2015-10-02       Impact factor: 8.327

Review 3.  COLD-PCR Technologies in the Area of Personalized Medicine: Methodology and Applications.

Authors:  Florence Mauger; Alexandre How-Kit; Jörg Tost
Journal:  Mol Diagn Ther       Date:  2017-06       Impact factor: 4.074

4.  Denaturation-Enhanced Droplet Digital PCR for Liquid Biopsies.

Authors:  Mariana Fitarelli-Kiehl; Fangyan Yu; Ravina Ashtaputre; Ka Wai Leong; Ioannis Ladas; Julianna Supplee; Cloud Paweletz; Devarati Mitra; Jonathan D Schoenfeld; Sareh Parangi; G Mike Makrigiorgos
Journal:  Clin Chem       Date:  2018-10-01       Impact factor: 8.327

Review 5.  Circulating Cell-Free Tumour DNA in the Management of Cancer.

Authors:  Glenn Francis; Sandra Stein
Journal:  Int J Mol Sci       Date:  2015-06-19       Impact factor: 5.923

Review 6.  The feasibility of using mutation detection in ctDNA to assess tumor dynamics.

Authors:  Xin Yi; Jianhui Ma; Yanfang Guan; Rongrong Chen; Ling Yang; Xuefeng Xia
Journal:  Int J Cancer       Date:  2017-03-02       Impact factor: 7.396

7.  Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics.

Authors:  Joost H van Ginkel; Daan A van den Broek; Joyce van Kuik; Dorothé Linders; Roel de Weger; Stefan M Willems; Manon M H Huibers
Journal:  Cancer Med       Date:  2017-09-21       Impact factor: 4.452

Review 8.  Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities.

Authors:  Sylvia Annabel Dass; Kim Liu Tan; Rehasri Selva Rajan; Noor Fatmawati Mokhtar; Elis Rosliza Mohd Adzmi; Wan Faiziah Wan Abdul Rahman; Tengku Ahmad Damitri Al-Astani Tengku Din; Venugopal Balakrishnan
Journal:  Medicina (Kaunas)       Date:  2021-01-12       Impact factor: 2.430

9.  The potential for liquid biopsies in the precision medical treatment of breast cancer.

Authors:  Victoria A Forte; Dany K Barrak; Mostafa Elhodaky; Lily Tung; Anson Snow; Julie E Lang
Journal:  Cancer Biol Med       Date:  2016-03       Impact factor: 4.248

Review 10.  Digital PCR as an Emerging Tool for Monitoring of Microbial Biodegradation.

Authors:  Yiqi Cao; Miao Yu; Guihua Dong; Bing Chen; Baiyu Zhang
Journal:  Molecules       Date:  2020-02-06       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.